Clinical Trial Update: Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women [Phase 3]

View source ↗

Summary

A Phase 3 trial of Desvenlafaxine succinate (DVS) for Major Depressive Disorder in midlife men and women is being updated, with the current status listed as unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate (Desvenlafaxine succinate)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Major Depressive Disorder, Menopausal Staging and Vasomotor Symptoms (for Females) | Phase 3 | Status: UNKNOWN